Ad is loading...
MENU

SYRS Syros Pharmaceuticals Forecast, Technical & Fundamental Analysis

a therapeutics company focusing on discovering and developing novel gene control therapies

Industry Biotechnology
SYRS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
SYRS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SYRS is expected to report earnings to rise 346.87% to -71 cents per share on March 06

Syros Pharmaceuticals SYRS Stock Earnings Reports
Q4'24
Est.
$-0.71
Q3'24
Beat
by $0.52
Q2'24
Beat
by $0.18
Q1'24
Beat
by $0.75
Q4'23
Est.
$-2.18
The last earnings report on October 31 showed earnings per share of -15 cents, beating the estimate of -68 cents. With 6.32M shares outstanding, the current market capitalization sits at 6.96M.
A.I. Advisor
published General Information

General Information

a therapeutics company focusing on discovering and developing novel gene control therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
35 CambridgePark Drive
Phone
+1 617 744-1340
Employees
68
Web
https://www.syros.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KAVL0.940.02
+2.17%
Kaival Brands Innovations Group
UNFI21.660.21
+0.98%
United Natural Foods
WSFS57.47-0.05
-0.09%
WSFS Financial Corp
MORN337.57-5.42
-1.58%
Morningstar
BDSX1.35-0.06
-3.93%
Biodesix

SYRS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRS has been loosely correlated with XFOR. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRS jumps, then XFOR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRS
1D Price
Change %
SYRS100%
-5.74%
XFOR - SYRS
50%
Loosely correlated
-1.59%
ORMP - SYRS
33%
Poorly correlated
-4.50%
CTXR - SYRS
32%
Poorly correlated
-39.10%
KNTPF - SYRS
32%
Poorly correlated
N/A
AXON - SYRS
30%
Poorly correlated
-0.86%
More